<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05050656</url>
  </required_header>
  <id_info>
    <org_study_id>FMASU R 63/ 2021</org_study_id>
    <nct_id>NCT05050656</nct_id>
  </id_info>
  <brief_title>Oral Duloxetine as a Premedication for Postoperative Pain Control</brief_title>
  <official_title>&quot;Preoperative Oral Duloxetine: Does it Affect Duration of Spinal Anesthesia and Early Postoperative Pain After Arthroscopic ACL Repair?&quot; a Prospective, Randomized, Double-blind Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to use duloxetine as premedication in Anterior cruciate ligament&#xD;
      repair under spinal anesthesia and evaluate the effect on onset and duration of spinal&#xD;
      anesthesia and postoperative pain control.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We designed this randomized, double-blind study to evaluate the effectiveness of&#xD;
      administration of oral duloxetine 2 hours preoperatively on the onset and the duration of the&#xD;
      spinal anesthesia in arthroscopic anterior cruciate ligament (ACL) repair and the role of&#xD;
      duloxetine on postoperative analgesia.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 15, 2021</start_date>
  <completion_date type="Actual">July 29, 2021</completion_date>
  <primary_completion_date type="Actual">July 28, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assess the onset of spinal anesthesia</measure>
    <time_frame>20 min</time_frame>
    <description>Time to T10 sensory block and time to Bromage 1 motor block</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of spinal anesthesia</measure>
    <time_frame>4 hours</time_frame>
    <description>Two-dermatomes regression for sensory recovery and return to Bromage 2 for motor recovery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>24 hours</time_frame>
    <description>Will be assessed by the patient using the visual analog scale (VAS, 0=no pain; 10=worst possible pain) every 4hrs up to 24hrs after the operation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time for first postoperative rescue analgesia request, frequency, and total morphine consumption</measure>
    <time_frame>24 hours</time_frame>
    <description>All participants will receive intravenous paracetamol, one gram every 8hrs, VAS score of 4 or more will receive 3 mg morphine intravenously and not be repeated more frequently than 4hrs limited to 12 mg morphine per 24hrs after operation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Group D (duloxetine group)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Two hours before surgery, participants received oral duloxetine 60 mg tablets in the ward then transferred to OR to receive spinal anesthesia before surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C (control group)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Two hours before surgery, participants received oral placebo tablets in the ward then transferred to OR to receive spinal anesthesia before surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Duloxetine 60mg</intervention_name>
    <description>Duloxetine is a selective SNRI prescribed in depression, anxiety, and chronic pain like diabetic neuropathy and fibromyalgia, it acts through central and peripheral pain modulation</description>
    <arm_group_label>Group D (duloxetine group)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>placebo tablets identical to duloxetine tablets</description>
    <arm_group_label>Group C (control group)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  American Society of Anesthesiologists I or II.&#xD;
&#xD;
          -  Sex: Both sexes.&#xD;
&#xD;
          -  Age between 18 and 50.&#xD;
&#xD;
          -  Height 155-180 cm.&#xD;
&#xD;
          -  Patients scheduled for arthroscopic anterior cruciate ligament (ACL) repair under&#xD;
             spinal anesthesia.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Declining to give written informed consent.&#xD;
&#xD;
          -  History of allergy to the medications used in the study.&#xD;
&#xD;
          -  Had a history of drug or alcohol abuse.&#xD;
&#xD;
          -  Taking opioids or sedative medications.&#xD;
&#xD;
          -  Inability to communicate with patients to evaluate the postoperative pain.&#xD;
&#xD;
          -  Need for postoperative ICU hospitalization.&#xD;
&#xD;
          -  Hepatic or renal failure.&#xD;
&#xD;
          -  Patients with a history of taking duloxetine or any SSRIs.&#xD;
&#xD;
          -  Contraindications to regional anesthesia (including coagulopathy and local infection).&#xD;
&#xD;
          -  Psychiatric disorders with antipsycotics or antidepressants (tricylic or MAOIs).&#xD;
&#xD;
          -  Antiplatelets (aspirin, clopidogrel) or anticoagulant (warfarin).&#xD;
&#xD;
          -  Quinolones (ciprofloxacin).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>tamer abdelaziz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of medicine, Ain Shams University, Cairo, Egypt</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>faculty of medicine, Ain Shams University</name>
      <address>
        <city>Cairo</city>
        <zip>11591</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 10, 2021</study_first_submitted>
  <study_first_submitted_qc>September 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 20, 2021</study_first_posted>
  <last_update_submitted>September 10, 2021</last_update_submitted>
  <last_update_submitted_qc>September 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Tamer Samir Abdelsalam</investigator_full_name>
    <investigator_title>Lecturer of Anesthesia</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Duloxetine Hydrochloride</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

